
A Tariff Tally & Blackstone’s Former President Tony James 2/27/25
Squawk Pod
Financial Challenges and Corporate Ethics in Biotech
This chapter explores the financial difficulties biotech companies face due to funding cuts at the FDA and their potential effects on clinical trials. It also examines the ethical implications of private equity practices, the complexities of taxation, and the influence of corporate diversity policies in changing political climates. Through discussions on cost-cutting strategies and corporate philosophies, the chapter highlights the intricate relationship between market uncertainty and executive decision-making.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.